This study is currently on hold. The study is designed to characterize the pharmacokinetics of DLM using a model-based...
A5314 is a phase II randomized, double-blind, placebo-controlled 36-week trial that will examine the safety and efficacy of...
A5329 is a study for people who are infected with both HIV and the Hepatitis C virus (HCV) and have never taken Hepatitis C...
P1073 is a case controlled prospective, clinical, observational and pathogenesis study of HIV-infected infants and children...
This purpose of this study is to evaluate the pharmacokinetics (PK), safety, and tolerability of bedaquiline (BDQ) in...
